A groundbreaking bill, HB 1802, is making waves in Texas as it moves towards a clinical trial involving psilocybin, MDMA, and ketamine, in collaboration with the Houston VA and Baylor Medical. With overwhelming support in the House and a focus on mental health treatment, this initiative represents a significant step forward in drug policy reform and veteran care. Advocates are determined to educate the public and push for legislative change that could set a precedent across the United States.
